Korea Investment Corp
RVMD icon

Korea Investment Corp’s Revolution Medicines RVMD Stock Holding History

Korea Investment Corp’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Sell
60,100
-6,361
-10% -$929K 0.02% 462
2026
Q1 		$6.46M Buy
+66,461
New +$6.71M 0.01% 587

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Korea Investment Corp's RVMD Position: Q2 2026 in Review

Korea Investment Corp reduced its Revolution Medicines (RVMD) stake by 9.6% in Q2 2026, selling an estimated $929K and leaving 60,100 shares worth $11.3M. The position accounts for 0.02% of the portfolio, ranked #462.

Korea Investment Corp first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Korea Investment Corp held 60,100 shares of Revolution Medicines worth $11.3M as of Q2 2026.
  • Korea Investment Corp sold 6,361 Revolution Medicines shares in Q2 2026, an estimated $929K.
  • Revolution Medicines made up 0.02% of Korea Investment Corp's portfolio in Q2 2026, its #462 holding.
  • Korea Investment Corp first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.